STAT May 22, 2024
Good morning. About a month ago, when I first started writing this newsletter, I shared the devastating news that the famed rat hole here in Chicago was being removed. But as summer approaches, it appears there now may be a new animal-shaped indentation for us all to obsess over — the Chicago cicada hole.
Now let’s get into the biotech news of the day.
The need-to-know this morning
- Biogen is acquiring Human Immunology Biosciences, a privately held developer of drugs for immune-related diseases, for $1.15 billion and up to $650 million in additional payments if certain milestones are met.
FDA unsure if Guardant’s test can be used for first-line cancer screening
From STAT’s Jonathan Wosen: The FDA is...
Today's Sponsors
Today's Sponsor